Algodystrophy (CRPS): Symptoms, Causes, Diagnosis, and Treatment

What is Algodystrophy?

Algodystrophy, more formally known as Complex Regional Pain Syndrome (CRPS), is a form of chronic, persistent neuropathic pain that typically affects one limb, most commonly an arm or a leg. It is classified as a neuropathic pain condition because it arises from dysfunction in the nervous system itself, rather than simply from ongoing tissue damage. What makes CRPS clinically distinctive and deeply frustrating for both patients and clinicians is that the pain experienced is profoundly disproportionate in both intensity and duration to the injury or event that triggered it.

CRPS develops following an injury of various kinds, such as a trauma, a surgical procedure, a stroke, or even a heart attack. It is divided into two recognized subtypes based on the nature of the triggering event:

• CRPS Type I (previously known as Reflex Sympathetic Dystrophy or RSD): Develops following an injury to soft tissues, bones, or organs, without identifiable damage to a specific peripheral nerve. This is the more common form, accounting for approximately 90% of cases.

• CRPS Type II (previously known as Causalgia): Develops following demonstrable injury to a peripheral nerve. The clinical features may be indistinguishable from Type I, but a specific nerve lesion can be identified on examination or neurophysiological testing.

In both types, the cardinal features are the same: pain that is out of proportion to the underlying cause, that persists far longer than expected, and that is accompanied by a constellation of autonomic, motor, and trophic disturbances that together substantially impair quality of life.

CRPS can affect any joint or limb region, including the foot, ankle, knee, hip, hand, wrist, and shoulder. The distribution of pain is typically regional, covering an entire limb or part of it, rather than following the territory of a single nerve or dermatome.

It is important to emphasize from the outset that algodystrophy is not a malignant condition and cannot undergo cancerous transformation. Although it is a severe and potentially debilitating disorder, it does not carry the risk of malignancy.

The prognosis is highly variable and often uncertain: the condition may spontaneously remit, even after many years; may remain stable for extended periods; or, in a minority of cases, may spread to involve other regions. Early diagnosis and prompt initiation of treatment are consistently associated with better outcomes, which makes clinical awareness of this condition particularly important.

Anatomy Review: The Nervous System

To understand the pathophysiology of CRPS, a brief review of the relevant anatomy of the nervous system is helpful.

The nervous system is organized hierarchically:

Central Nervous System (CNS):

• Brain
• Spinal cord

Peripheral Nervous System (PNS):

• All nerves outside the brain and spinal cord

The peripheral nervous system is further subdivided into:

Somatic nervous system (under voluntary control):

• Sensory (afferent) division: Carries sensory information from the body to the CNS (touch, pain, temperature, proprioception)
• Motor (efferent) division: Carries motor commands from the CNS to skeletal muscles

Autonomic nervous system (largely involuntary, it controls functions not under conscious control):

• Sympathetic nervous system (“fight or flight” responses):

  • Release of cortisol and adrenaline (stress hormones) into the circulation
  • Pupil dilation and accommodation for distant vision
  • Increased cardiac output, heart rate, and blood pressure
  • Bronchodilation
  • Coronary artery dilation
  • Dilation of skeletal muscle blood vessels
  • Constriction of peripheral blood vessels
  • Reduced blood flow to skin and visceral organs (except heart and lungs)
  • Suppression of digestive and renal function

• Parasympathetic nervous system (“rest and digest”, responsible for recovery, digestion, and restoration of baseline function)

• Enteric nervous system (the network of nerve fibers that innervates the gastrointestinal tract)

The sympathetic nervous system plays a central and particularly important role in CRPS. Current understanding suggests that dysregulation of sympathetic activity, along with the sensitization of peripheral pain receptors (nociceptors) to sympathetic neurotransmitters such as noradrenaline, is a key driver of the sustained pain and autonomic disturbances that characterize the condition.

Understanding this anatomy helps explain why CRPS produces such a distinctive combination of pain, skin color changes, temperature asymmetry, sweating abnormalities, and trophic changes. All of these reflect dysregulated sympathetic control of the affected limb’s vasculature, sweat glands, and skin.

---

Causes

The causes underlying the development of Complex Regional Pain Syndrome remain incompletely understood, despite decades of research. What is clear is that CRPS represents a pathological response of the nervous system to an initiating injury. This response is abnormal in its intensity, duration, and resistance to resolution.

Triggering Events

CRPS Type I

Type I CRPS develops following injuries that do not damage a specific peripheral nerve, including:

• Injuries to the hands or feet: Even minor fractures, sprains, or soft tissue injuries can trigger CRPS in susceptible individuals
• Crush injuries: Injuries involving significant compression of tissues
• Acute myocardial infarction (heart attack): CRPS of the upper limb (particularly the shoulder-hand syndrome) can follow cardiac events
• Cerebral stroke: Post-stroke CRPS, typically affecting the hemiplegic limb, is a recognized complication
• Malignancies of the lung, breast, ovary, or central nervous system: These can trigger a paraneoplastic form of CRPS
• Prolonged immobilization of a limb: Often resulting from the treatment of the original injury (e.g., casting or splinting), immobilization itself can contribute to the development of CRPS. This finding has important implications for how injuries are managed.

CRPS Type II

Type II CRPS develops following demonstrable injury to a peripheral nerve, producing the full CRPS syndrome in the territory of that nerve and beyond. Causes include:

• Surgical nerve injury
• Traumatic nerve lacerations or stretch injuries
• Compressive nerve injuries (e.g., following prolonged positioning during surgery)
• Iatrogenic nerve damage from injections or procedures

Pathophysiological Mechanisms

While the triggering events are diverse, they are thought to initiate a cascade of pathological processes, most of which are mediated by the sympathetic nervous system, that collectively sustain pain and inflammation long after the original injury should have resolved. The currently recognized mechanisms include:

• Increased central sympathetic activity: Enhanced activation of sympathetic pathways in the spinal cord and brain, producing increased noradrenaline release at peripheral sympathetic nerve endings in the affected limb.

• Sensitization of peripheral nociceptors to noradrenaline: In CRPS, pain receptors (nociceptors) in the affected tissues develop an abnormal sensitivity to noradrenaline, the primary neurotransmitter of the sympathetic nervous system. Normally, noradrenaline does not stimulate nociceptors. In CRPS, it does, creating a pathological coupling between sympathetic activation and pain generation. This is sometimes described as “sympathetically maintained pain”.

• Increased release of neuropeptides: Enhanced release of inflammatory neuropeptides, including Substance P and calcitonin gene-related peptide (CGRP), from sensory nerve endings in the affected area. These substances promote neurogenic inflammation, which involves vasodilation, plasma extravasation, and sensitization of nociceptors. This creates a local inflammatory microenvironment that perpetuates the cycle of pain and tissue changes.

• Central sensitization: Changes in the central nervous system, including the spinal cord dorsal horn and supraspinal pain processing centers, cause amplification of pain signals (a phenomenon known as “wind-up”). Stimuli that would normally be perceived as non-painful or mildly painful are processed as severely painful, and the threshold for pain activation is lowered.

• Neuroinflammation and immune dysregulation: Emerging evidence suggests that inflammatory immune responses, including mast cell activation and cytokine release, contribute to the maintenance of CRPS. This may explain why some patients respond to anti-inflammatory treatments.

• Cortical reorganization: Brain imaging studies in CRPS have demonstrated changes in the somatosensory and motor cortices, including a shrinkage of the cortical representation of the affected limb. These central changes likely contribute to the motor, sensory, and perceptual disturbances of CRPS and may persist even after peripheral pain has improved.

Despite the recognition of these mechanisms, a fundamental question remains unanswered: why do only some individuals develop CRPS following apparently similar injuries? Genetic susceptibility, psychological factors, the specific characteristics of the injury, and its management all appear to play roles. However, the precise interplay of these factors is not yet understood.

Epidemiology

CRPS affects people of all ages but shows a notable predilection for:

• Women: The female-to-male ratio is approximately 2–3:1, with women being significantly more commonly affected across most studies.
• Young adults: The peak incidence is in the fourth and fifth decades of life, though CRPS can occur at any age including childhood and old age.
• Upper limbs: The upper extremities (arm, wrist, hand) are more frequently affected than the lower extremities (leg, ankle, foot, knee, hip), though lower limb involvement, particularly following foot and ankle injuries, is common.

The estimated incidence of CRPS ranges from approximately 5.5 to 26.2 per 100,000 person-years depending on the diagnostic criteria used and the population studied.

---

Symptoms

The hallmark of algodystrophy is a heterogeneous and polymorphic symptom complex; no two patients present identically, and symptoms can change over time within the same patient. What all presentations share is a burning or aching pain that:

• Is disproportionate to any identifiable tissue injury
• Is regional in distribution, typically covering an entire limb rather than following the territory of a single nerve
• Does not resolve as expected with normal healing, and characteristically worsens with emotional stress and lifestyle changes
• Significantly limits the use of the affected limb

Surrounding this core pain, a range of additional disturbances, such as autonomic, sensory, motor, and trophic ones, contribute to the profound reduction in quality of life experienced by patients. The psychosomatic impact of unrelenting, disproportionate pain, particularly in the context of a condition that is often poorly understood by the patient’s social environment, can be severe.

Onset and Clinical Course

The clinical presentation of CRPS typically evolves through recognizable (though not invariable) phases:

Early phase:

• Onset of pain, often within days to weeks of the triggering injury
• Swelling (edema) of the affected limb
• Redness and warmth of the overlying skin
• Marked temperature fluctuations between the affected and unaffected limb
• Hypersensitivity, particularly to cold and touch (allodynia and hyperalgesia)

Established phase:

• Persisting severe pain
• Skin color and temperature changes may become more variable
• Progressive limitation of joint range of motion
• Development of motor disturbances
• Early trophic changes (skin, hair, nail changes)

Late/chronic phase:

• Skin becomes thin, pale, and glossy
• Significant muscle atrophy and joint contractures
• Bony atrophy (osteoporosis-like changes on imaging)
• Motor disturbances may be severe (dystonia, fixed deformities)
• Psychological complications prominent

Not all patients progress through these stages, and spontaneous partial or complete remission can occur at any point.

Sensory Abnormalities

Vasomotor and Skin Changes

The autonomic nervous system (particularly the sympathetic division) controls the caliber of blood vessels in the skin, determining skin color and temperature. Dysregulation of this control in CRPS produces characteristic visible changes:

• Erythema (redness): Due to increased skin blood flow in the affected area; may alternate with pallor or cyanosis as the condition evolves
• Skin mottling: A patchy, blotchy discoloration reflecting irregular vascular tone
• Temperature asymmetry: The affected limb may be noticeably warmer or cooler than the contralateral (unaffected) limb, reflecting abnormal sympathetic vasomotor control. Temperature differences of more than 1°C between limbs are clinically significant.
• Allodynia: Pain provoked by normally non-painful stimuli. Even light touch, the pressure of clothing against the skin, or gentle air currents can cause severe pain. This is one of the most distressing and functionally disabling features of CRPS.
• Hyperalgesia: An exaggerated pain response to stimuli that are mildly painful in normal circumstances (e.g., a light pinprick producing intense, burning pain)

Sudomotor Abnormalities

The sweat glands of the affected limb are under sympathetic control, and their dysregulation in CRPS produces:

• Hyperhidrosis: Increased sweating in the affected area (a warm, moist limb)
• Anhidrosis: Reduced sweating, resulting in dry skin
• These changes may alternate and are often asymmetric compared to the unaffected limb

Edema

Swelling of the affected limb, particularly the hand, wrist, foot, or ankle, is almost universal in the early phases of CRPS. The edema results from neurogenic inflammation (substance P and CGRP-mediated plasma extravasation), increased capillary permeability, and impaired lymphatic drainage.

Motor Abnormalities

Motor disturbances are a clinically important but sometimes underemphasized component of CRPS:

• Tremor: Fine or coarse tremor of the affected limb, particularly the hand or fingers
• Muscle weakness: Progressive weakness of the muscles in the affected limb, partly due to disuse atrophy and partly due to direct neural dysfunction
• Muscle spasms: Involuntary, often painful contractions of muscles in the affected region
• Fasciculations: Visible, spontaneous muscle twitching
• Dystonia: A particularly severe motor complication in which sustained involuntary muscle contractions produce abnormal postures of the affected limb. Common dystonic postures in lower limb CRPS include:
  • Equinovarus foot position: The foot is pulled downward and inward, resembling a “clubfoot” posture, making weight-bearing extremely difficult or impossible
  • Fixed finger flexion: The fingers are held in a flexed position and cannot be passively straightened without extreme pain
• Reduced range of motion: Progressive stiffening of the affected joints due to a combination of pain-related guarding, dystonia, and developing joint contractures

Trophic Changes

Prolonged CRPS produces characteristic changes in the skin, nails, hair, and bone of the affected region, reflecting the chronic disruption of normal tissue maintenance by dysregulated autonomic and inflammatory processes.

• Skin atrophy: Thinning, fragility, and loss of normal skin texture in the affected area.
• Translucent or glossy skin: The skin takes on a thin, shiny, almost transparent appearance, which is one of the most recognizable trophic features of established CRPS.
• Alopecia: Hair loss in the affected region, reflecting impaired circulation and trophic support to hair follicles
• Brittle and fissured nails: Nails become fragile, ridged, and prone to splitting.
• Bone atrophy (Sudeck’s atrophy): Progressive demineralization of bone in the affected region, producing a patchy osteoporosis-like pattern visible on X-ray. This is sometimes called “Sudeck’s atrophy” after the German surgeon who first described it. The bone loss can be severe and increases the risk of pathological fractures.

Psychological Consequences

The psychological impact of CRPS is profound and should not be underestimated. Living with unrelenting, severe, and disproportionate pain in a condition that is often misunderstood, misdiagnosed, or disbelieved by both healthcare professionals and the patient’s social circle takes a severe toll:

• Depression: A very common complication of CRPS, driven by the combination of chronic pain, functional limitation, social isolation, and the sense of helplessness that often accompanies a condition for which treatment is frequently inadequate
• Anxiety and stress disorders: Anticipatory anxiety about pain triggers, social anxiety about disability and appearance, and generalized anxiety all commonly develop
• Anger and aggression: Directed at the healthcare system (which often takes years to provide an accurate diagnosis and effective treatment), at family and friends who may not understand the severity of the condition, or internalized as self-directed frustration
• Behavioral changes: Avoidance of activities, social withdrawal, and changes in interpersonal functioning

The psychological complications of CRPS form a vicious cycle with the physical symptoms. Stress and anxiety activate the sympathetic nervous system, which directly worsens the pain and autonomic disturbances; this then increases psychological distress. Addressing the psychological dimension of CRPS is therefore not an optional add-on to treatment, but an essential component of a comprehensive care plan.

Functional Consequences

The combination of severe pain, motor disturbances, and trophic changes in CRPS can produce profound functional disability:

• Limited mobility and restricted use of the affected limb: Patients often cannot bear weight on an affected leg, cannot grasp objects with an affected hand, or cannot raise an affected arm
• Joint contractures: If range of motion is not maintained through physiotherapy, permanent contractures may develop, locking joints in dysfunctional positions.
• Complications in patients with amputated limbs: Patients who have undergone amputation and subsequently develop CRPS (including phantom limb pain-associated CRPS) may have great difficulty fitting and using prosthetic limbs, significantly limiting their rehabilitation potential and independence

---

Diagnosis

The neurologist is the primary specialist for the diagnosis and management of Complex Regional Pain Syndrome. The diagnostic process requires careful clinical history-taking, thorough neurological examination, and the systematic application of validated diagnostic criteria. The Budapest Criteria represent the current international standard for CRPS diagnosis.

The Budapest Criteria

The Budapest Criteria were developed to standardize CRPS diagnosis and to distinguish it from other pain conditions. For a diagnosis of CRPS to be made, all of the following requirements must be satisfied:

1. Disproportionate continuing pain: The patient must have continuous pain that is disproportionate to any inciting event or ongoing tissue damage, in terms of both its intensity and its duration. This is the sine qua non of CRPS: without disproportionate pain, the diagnosis cannot be made.

2. Symptom criterion: The patient must report at least one symptom in three or more of the following four categories:

• Sensory: Hyperesthesia (increased sensitivity to tactile, thermal, or painful stimuli) and/or allodynia (pain provoked by normally non-painful stimuli such as light touch or clothing)
• Vasomotor: Asymmetric skin color changes (redness or cyanosis) or skin temperature asymmetry
• Sudomotor/Edema: Sweating abnormalities (increased or decreased) and/or edema (swelling)
• Motor/Trophic: Motor dysfunction (tremor, weakness, dystonia, reduced range of motion) and/or trophic changes (skin, nail, or hair abnormalities)

3. Sign criterion: The clinician must observe at least one sign in two or more of the same four categories on physical examination. (Signs are objectively observed by the examiner; symptoms are subjectively reported by the patient.)

4. No other diagnosis better explains the findings: Before diagnosing CRPS, any other condition that could more parsimoniously explain the patient’s complete symptom and sign picture must be excluded.

It is worth noting that there is also a research version of the Budapest Criteria, which is more stringent (requiring symptoms in all four categories and signs in two or more), designed to ensure specificity in research studies.

Clinical Examination

The neurological examination in suspected CRPS includes:

• Assessment of pain characteristics: Location, quality (burning, aching, stabbing), severity (numeric rating scale), aggravating and relieving factors, temporal pattern
• Sensory testing: Light touch, pinprick, temperature discrimination, and vibration sense, comparing the affected and unaffected limbs
• Detection of allodynia: Assessing the pain response to gentle touch, stroking, and pressure
• Vasomotor assessment: Visual inspection of skin color and temperature; infrared thermometry to objectively document temperature asymmetry (>1°C between limbs is significant)
• Sudomotor assessment: Observation of sweating differences between limbs
• Edema assessment: Visual inspection and circumferential limb measurement
• Motor examination: Muscle strength, tone, reflexes, range of motion, presence of tremor, fasciculations, or dystonia
• Trophic assessment: Inspection of skin texture, hair distribution, and nail condition

Supplementary Investigations

While the diagnosis of CRPS is primarily clinical, several investigations can provide supportive evidence and help exclude alternative diagnoses:

• Plain X-rays: May show patchy periarticular osteopenia (Sudeck’s atrophy pattern) in established CRPS, though this finding is non-specific and may not be present early
• Three-phase bone scintigraphy (bone scan): In early CRPS, increased uptake of the bone tracer in the periarticular regions of the affected limb is a characteristic finding. In chronic CRPS, decreased uptake may be seen. Bone scintigraphy has a sensitivity of approximately 60% and specificity of 80% for CRPS when interpreted in the appropriate clinical context.
• MRI: Can identify early bone marrow edema and soft tissue changes, and is useful for excluding other diagnoses (e.g., osteomyelitis, fracture, tumor)
• Quantitative sudomotor axon reflex testing (QSART): Objectively quantifies sweat output and can document sudomotor abnormalities
• Skin temperature measurement: Infrared thermometry or liquid crystal thermography provides an objective measure of temperature asymmetry between limbs
• Nerve conduction studies and electromyography (EMG): Used particularly in CRPS Type II to document the peripheral nerve injury, and to exclude other neuropathic conditions in the differential diagnosis

Differential Diagnosis

Conditions that must be excluded before diagnosing CRPS include:

• Peripheral neuropathies (e.g., diabetic, alcoholic): diffuse rather than regional; no autonomic disturbances specific to a single limb
• Vascular disorders (e.g., deep vein thrombosis, peripheral arterial disease, Raynaud’s phenomenon): specific vascular findings on Doppler ultrasound or arteriography
• Inflammatory arthritis (e.g., rheumatoid arthritis, reactive arthritis): characteristic joint involvement pattern; serological markers
• Bursitis or tendinopathy: Localized rather than regional; resolves with appropriate treatment
• Infection (e.g., osteomyelitis, septic arthritis): fever, elevated inflammatory markers, specific microbiological findings
• Psychological conditions (e.g., somatic symptom disorder, factitious disorder): diagnosis of exclusion after thorough clinical evaluation
• Lymphedema: Non-pitting edema; specific lymphoscintigraphic findings
• Fibromyalgia: Widespread rather than regional; specific fibromyalgia tender points

---

Treatment and Remedies

The treatment of algodystrophy is complex and, it must be acknowledged, frequently unsatisfactory, particularly when initiated late in the clinical course. Because our understanding of the precise pathophysiological mechanisms underlying CRPS remains incomplete, we lack treatments that can reliably target and eliminate the fundamental disorder. Current therapy is therefore multimodal, combining multiple simultaneous approaches, with the dual aims of:

1. Alleviating pain to a degree that permits active participation in rehabilitation
2. Restoring and maintaining function of the affected limb through physiotherapy and occupational rehabilitation

Early initiation of treatment is strongly associated with better outcomes, underscoring the importance of early diagnosis. The following evidence-based treatment modalities are currently in use:

Pharmacological Therapy

Pharmacological treatment is aimed at controlling neuropathic pain and reducing the neuroinflammatory process. It is important to recognize that drugs used in CRPS are primarily symptomatic; they reduce pain to facilitate participation in physiotherapy rather than provide a cure. Results are often incomplete.

First-line neuropathic pain agents:

• Tricyclic antidepressants (e.g., amitriptyline, nortriptyline): Work through sodium channel blockade and modulation of serotonin and noradrenaline reuptake to reduce neuropathic pain. Effective at low doses below the antidepressant threshold. Side effects include dry mouth, sedation, and constipation. Antidepressants of the SNRI class (e.g., duloxetine) may also be beneficial.

• Anticonvulsants / antiepileptic drugs (e.g., gabapentin, pregabalin): Modulate calcium channels in pain pathways, reducing central sensitization. These are widely used as first-line agents for neuropathic pain in CRPS, with moderate evidence of efficacy.

• Corticosteroids: Particularly useful in early CRPS where neurogenic inflammation is prominent. Short courses of oral prednisolone can reduce edema, skin changes, and pain in the early phase, but are not recommended for long-term use.

• Bisphosphonates (e.g., alendronate, pamidronate, neridronate): Inhibit osteoclast-mediated bone resorption (addressing the Sudeck’s atrophy component) and have anti-inflammatory and analgesic properties in CRPS, supported by randomized controlled trial evidence. Intravenous formulations appear more effective than oral.

• Calcitonin: Has both bone-protective and analgesic properties and may be used, particularly in patients with significant bone involvement.

• Topical agents: Topical lidocaine patches, capsaicin patches (which desensitize TRPV1 nociceptors through repeated application), and topical NSAIDs may provide localized pain relief with minimal systemic side effects.

Second-line agents:

• Opioid analgesics: In carefully selected patients with severe refractory CRPS pain, opioid analgesics may be used. However, their use in chronic pain requires careful consideration because: (a) evidence of long-term efficacy in CRPS specifically is limited, (b) opioids can paradoxically increase pain sensitivity (opioid-induced hyperalgesia) with prolonged use, and (c) the risks of dependence and adverse effects must be weighed against potential benefits. They may be useful for short periods to enable participation in physiotherapy.

• Ketamine: An NMDA receptor antagonist that can interrupt central sensitization. Low-dose ketamine infusions, administered in specialist inpatient settings, have shown promising results in refractory CRPS. They produce periods of pain relief that may outlast the infusion. The optimal dosing protocol and long-term safety profile are areas of ongoing research.

• Free radical scavengers: Some evidence supports the use of antioxidants, such as topical dimethyl sulfoxide (DMSO) and oral N-acetylcysteine, based on the hypothesis that excess free radical production contributes to CRPS. Vitamin C (ascorbic acid) given prophylactically after wrist fracture has been shown to reduce the incidence of CRPS in randomized trials.

Physiotherapy

Physiotherapy is the cornerstone of CRPS management and is arguably the most important single intervention. The goals of physiotherapy are:

• Desensitization of the affected limb: Graduated exposure of the limb to stimuli of increasing intensity (tactile, thermal) to gradually normalize the hypersensitized sensory system.
• Maintenance and restoration of joint range of motion: Preventing and reversing joint contractures through carefully graded active and passive mobilization.
• Increasing muscle strength: Addressing disuse atrophy and neurogenic weakness through progressive resistance exercise.
• Graded motor imagery: A technique increasingly supported by evidence, involving a sequence of mental exercises (limb laterality recognition, imagined movements, and mirror therapy) designed to normalize the cortical representation of the affected limb without triggering pain.
• Functional rehabilitation: Restoring the ability to perform activities of daily living and work-related tasks.

Physiotherapy in CRPS must be delivered with particular sensitivity, as aggressive mobilization can trigger severe pain flares and paradoxically worsen the condition. The key principle is graded exposure: gently challenging the pain and functional limitations in a structured, stepwise manner, with the patient always in control of the pace.

Mirror Therapy

A specialized rehabilitation technique with specific applications in CRPS, mirror therapy uses a mirror placed sagittally (vertically) between the two limbs. The patient watches the reflection of the unaffected limb in the mirror, creating the visual illusion that the affected limb is moving normally and without pain. This visual feedback is thought to normalize the cortical representation of the affected limb.

Mirror therapy is particularly well-established for:

• CRPS following stroke (affecting a hemiplegic limb)
• Phantom limb pain following amputation

Its evidence in post-traumatic CRPS is more preliminary but growing.

Psychological Therapy

Given the profound psychological impact of CRPS, and the bidirectional relationship between psychological state and pain intensity, psychological therapy is an essential component of comprehensive CRPS management, not an optional extra:

• Cognitive-behavioral therapy (CBT): Helps patients identify and modify maladaptive thought patterns (catastrophizing, avoidance) that amplify pain perception and disability. CBT can reduce fear-avoidance behaviors, improve coping strategies, and directly reduce the psychological comorbidities (depression, anxiety) that worsen outcomes.
• Acceptance and Commitment Therapy (ACT): An approach that helps patients develop psychological flexibility by learning to accept the presence of pain while committing to valued activities, rather than organizing life around pain avoidance.
• Biofeedback: Patients learn to consciously influence physiological parameters (skin temperature, muscle tension, heart rate variability) that are under autonomic control, potentially modulating the sympathetic dysregulation that drives CRPS symptoms.
• Pain psychology and multidisciplinary pain programs: Specialist pain psychology services and multidisciplinary pain management programs (combining medical, physiotherapy, and psychological approaches in an intensive structured format) represent the gold standard for patients with established, complex CRPS.

Sympathetic Nervous System Blockade

Sympathetic blockade, which temporarily or permanently interrupts sympathetic nerve transmission to the affected limb, is based on the rationale that sympathetically maintained pain is a key driver of CRPS in many patients:

• Stellate ganglion block: For upper limb CRPS, this involves an injection of local anesthetic around the stellate ganglion (a sympathetic ganglion in the neck) to block sympathetic outflow to the arm and hand.
• Lumbar sympathetic block: For lower limb CRPS, this involves an injection of local anesthetic around the lumbar sympathetic chain to block sympathetic outflow to the leg and foot.
• Intravenous regional sympathetic blockade (Bier block): Injection of a sympatholytic drug (e.g., guanethidine or bretylium) into an isolated limb vascular bed

Importantly, current evidence suggests that sympathetic blockade has limited effect on pain in most CRPS patients. It is more effective for the vasomotor and sudomotor disturbances (temperature asymmetry, abnormal sweating) than for the pain itself. This observation reflects the fact that not all CRPS pain is “sympathetically maintained”. Sympathetic blockade is therefore best viewed as one tool in a multimodal arsenal, particularly useful for improving the temperature and skin changes that impair physiotherapy participation.

Neuromodulation

For patients with severe, refractory CRPS who have not responded adequately to the above measures, neuromodulation offers a more invasive but potentially highly effective option:

• Spinal cord stimulation (SCS): Implantation of electrodes in the epidural space of the spinal cord, connected to a subcutaneous pulse generator. Electrical stimulation of the dorsal columns of the spinal cord modulates pain signal transmission, reducing the perception of pain in the affected limb. Multiple randomized controlled trials have demonstrated the efficacy of SCS in CRPS, with clinically significant and sustained pain reduction in a substantial proportion of patients. SCS is considered a cost-effective treatment for refractory CRPS.

• Dorsal root ganglion (DRG) stimulation: A newer neuromodulation technique that involves implanting electrodes at specific dorsal root ganglia. These are the nodes where sensory nerve cell bodies are located, just outside the spinal cord. DRG stimulation can provide more targeted and precise neuromodulation than conventional SCS, with particular promise for CRPS affecting the foot, groin, and other areas that can be difficult to target effectively with SCS. Recent comparative trials have demonstrated DRG stimulation to be superior to SCS for CRPS of the lower limb.

• Intrathecal drug delivery (neuroaxial infusion): Implantation of a catheter in the intrathecal space (within the spinal fluid) connected to an implanted programmable pump. Continuous infusion of drugs, typically opioids, baclofen (for dystonia), or local anesthetics, directly into the cerebrospinal fluid allows very high local concentrations with very low systemic dosing. This minimizes side effects while maximizing the analgesic effect. Particularly useful in patients with severe CRPS-associated dystonia (where intrathecal baclofen can dramatically reduce dystonic posturing).

Acupuncture and Complementary Therapies

Acupuncture is a traditional medicine technique that has been evaluated in CRPS. The evidence base remains limited, as high-quality randomized controlled trials are sparse. Consequently, it is not currently recommended as a primary treatment by most pain medicine guidelines. However, when practiced by appropriately trained and regulated healthcare professionals, acupuncture carries a very low risk of adverse effects and may provide additional benefit in some patients as a complement to evidence-based treatment.

Other complementary approaches that individual patients may find helpful as adjuncts include:

• Transcutaneous electrical nerve stimulation (TENS)
• Hydrotherapy and aquatic physiotherapy
• Mindfulness-based stress reduction (MBSR)
• Relaxation training

These should always be used as additions to, not replacements for, evidence-based treatment.

The Challenge of CRPS Management

It must be honestly acknowledged that despite the range of available treatments, adequately controlling the symptoms of CRPS remains a significant challenge for a substantial proportion of patients. The fundamental limitation is our incomplete understanding of the pathophysiological mechanisms underlying the syndrome. Without knowing precisely why and how CRPS develops and is maintained, we cannot yet design treatments that address its root cause rather than merely managing its symptoms.

Key principles for optimizing outcomes include:

• Earliest possible diagnosis and treatment initiation: Every study consistently finds that earlier treatment is associated with better outcomes. Any clinician encountering a patient with pain disproportionate to apparent tissue injury, accompanied by autonomic and trophic changes, should consider CRPS and refer promptly to a neurologist or specialist pain service.

• Genuine multimodal, multidisciplinary care: No single treatment is sufficient. The best outcomes are achieved by combining pharmacological pain control with intensive physiotherapy, psychological support, and (where appropriate) interventional treatments in a coordinated, individualized plan.

• Patient education and empowerment: Understanding the nature of CRPS, including the neurological basis of the disproportionate pain, the importance of active participation in physiotherapy, and realistic expectations about recovery, is essential for patient adherence and coping.

• Regular reassessment and treatment adjustment: Because CRPS can change over time and because treatment responses are variable, regular review and willingness to modify the treatment plan are essential.

• Addressing the psychological dimension: Psychological support is not a “soft” add-on but a core component of effective CRPS management. Depression, anxiety, and catastrophizing worsen pain and outcomes and must be actively addressed.

With comprehensive, early, and well-coordinated care, many patients with CRPS achieve meaningful improvement in pain and function, even if complete resolution remains elusive in established cases.

---

Sources and Bibliography

• Harden, R.N., Bruehl, S., Stanton-Hicks, M., & Wilson, P.R. (2007). “Proposed new diagnostic criteria for complex regional pain syndrome”. Pain Medicine, 8(4), 326–331.
• Birklein, F., O’Neill, D., & Schlereth, T. (2015). “Complex regional pain syndrome: An optimistic perspective”. Neurology, 84(1), 89–96.
• de Mos, M., de Bruijn, A.G., Huygen, F.J., et al. (2007). “The incidence of complex regional pain syndrome: A population-based study”. Pain, 129(1–2), 12–20.
• Bruehl, S. (2015). “Complex regional pain syndrome”. BMJ, 351, h2730.
• Kemler, M.A., Barendse, G.A., van Kleef, M., et al. (2000). “Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy”. New England Journal of Medicine, 343(9), 618–624.
• Deer, T.R., Levy, R.M., Kramer, J., et al. (2017). “Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: A randomized comparative trial”. Pain, 158(4), 669–681.
• Gierthmühlen, J., Maier, C., Baron, R., et al. (2012). “Sensory signs in complex regional pain syndrome and peripheral nerve injury”. Pain, 153(4), 765–774.
• MSD Manuals – Complex Regional Pain Syndrome
• Perez, R.S., Zollinger, P.E., Dijkstra, P.U., et al. (2010). “Evidence based guidelines for complex regional pain syndrome type 1”. BMC Neurology, 10, 20.
• Moseley, G.L. (2004). “Graded motor imagery is effective for long-standing complex regional pain syndrome: A randomised controlled trial”. Pain, 108(1–2), 192–198.
• Zollinger, P.E., Tuinebreijer, W.E., Breederveld, R.S., & Kreis, R.W. (2007). “Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures?” Journal of Bone and Joint Surgery (American volume), 89(7), 1424–1431.